

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 7.61984430 |
| 2 | oxygen transport (GO:0015671) | 7.07334775 |
| 3 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 6.75703893 |
| 4 | porphyrin-containing compound biosynthetic process (GO:0006779) | 6.43037260 |
| 5 | gas transport (GO:0015669) | 6.26410251 |
| 6 | tetrapyrrole biosynthetic process (GO:0033014) | 5.84885855 |
| 7 | heme biosynthetic process (GO:0006783) | 5.57272066 |
| 8 | skeletal muscle contraction (GO:0003009) | 5.36165119 |
| 9 | tricarboxylic acid cycle (GO:0006099) | 5.30668302 |
| 10 | sarcomere organization (GO:0045214) | 5.20089576 |
| 11 | hemoglobin metabolic process (GO:0020027) | 5.19605364 |
| 12 | creatine metabolic process (GO:0006600) | 5.10336700 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.99362398 |
| 14 | muscle filament sliding (GO:0030049) | 4.91082902 |
| 15 | actin-myosin filament sliding (GO:0033275) | 4.91082902 |
| 16 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.83587678 |
| 17 | porphyrin-containing compound metabolic process (GO:0006778) | 4.75742288 |
| 18 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.69204353 |
| 19 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.67267854 |
| 20 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.67266902 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.64015256 |
| 22 | cardiac myofibril assembly (GO:0055003) | 4.58183923 |
| 23 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.56641393 |
| 24 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.51881159 |
| 25 | actin filament-based movement (GO:0030048) | 4.50270963 |
| 26 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.48172120 |
| 27 | regulation of platelet aggregation (GO:0090330) | 4.46696141 |
| 28 | respiratory electron transport chain (GO:0022904) | 4.36265388 |
| 29 | cardiac muscle contraction (GO:0060048) | 4.35216127 |
| 30 | myofibril assembly (GO:0030239) | 4.35124800 |
| 31 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.34859267 |
| 32 | NADH metabolic process (GO:0006734) | 4.29809928 |
| 33 | oxidative phosphorylation (GO:0006119) | 4.29661346 |
| 34 | ATP synthesis coupled proton transport (GO:0015986) | 4.27246879 |
| 35 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.27246879 |
| 36 | electron transport chain (GO:0022900) | 4.26883716 |
| 37 | heart contraction (GO:0060047) | 4.19007663 |
| 38 | heart process (GO:0003015) | 4.19007663 |
| 39 | heme metabolic process (GO:0042168) | 4.11366230 |
| 40 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.01255888 |
| 41 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.00242967 |
| 42 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.98252433 |
| 43 | regulation of skeletal muscle contraction (GO:0014819) | 3.94072793 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.93155459 |
| 45 | actin-mediated cell contraction (GO:0070252) | 3.90420842 |
| 46 | myeloid cell development (GO:0061515) | 3.90363332 |
| 47 | regulation of oxidative phosphorylation (GO:0002082) | 3.85966087 |
| 48 | cell communication by electrical coupling (GO:0010644) | 3.85135946 |
| 49 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.83819701 |
| 50 | protein maturation by protein folding (GO:0022417) | 3.80159019 |
| 51 | regulation of cofactor metabolic process (GO:0051193) | 3.75993760 |
| 52 | regulation of coenzyme metabolic process (GO:0051196) | 3.75993760 |
| 53 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.75627336 |
| 54 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.74879406 |
| 55 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.73658473 |
| 56 | skeletal muscle adaptation (GO:0043501) | 3.70191884 |
| 57 | regulation of relaxation of muscle (GO:1901077) | 3.68602487 |
| 58 | detection of calcium ion (GO:0005513) | 3.65334179 |
| 59 | plasma membrane repair (GO:0001778) | 3.65278303 |
| 60 | regulation of actin filament-based movement (GO:1903115) | 3.63438414 |
| 61 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.62879094 |
| 62 | striated muscle contraction (GO:0006941) | 3.60314403 |
| 63 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.55135385 |
| 64 | succinate metabolic process (GO:0006105) | 3.54934558 |
| 65 | regulation of cell communication by electrical coupling (GO:0010649) | 3.54214983 |
| 66 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.52232525 |
| 67 | negative regulation of necroptotic process (GO:0060546) | 3.51585844 |
| 68 | regulation of the force of heart contraction (GO:0002026) | 3.50021358 |
| 69 | carnitine shuttle (GO:0006853) | 3.44009202 |
| 70 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.42647591 |
| 71 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.42647591 |
| 72 | response to insecticide (GO:0017085) | 3.40451407 |
| 73 | negative regulation of muscle hypertrophy (GO:0014741) | 3.39960378 |
| 74 | regulation of response to osmotic stress (GO:0047484) | 3.33788326 |
| 75 | receptor recycling (GO:0001881) | 3.31884916 |
| 76 | skeletal muscle tissue regeneration (GO:0043403) | 3.30216194 |
| 77 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.29914449 |
| 78 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.28316474 |
| 79 | melanin biosynthetic process (GO:0042438) | 3.28260046 |
| 80 | activation of protein kinase A activity (GO:0034199) | 3.28115806 |
| 81 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.27674947 |
| 82 | muscle contraction (GO:0006936) | 3.27448291 |
| 83 | ATP biosynthetic process (GO:0006754) | 3.27386059 |
| 84 | ubiquinone biosynthetic process (GO:0006744) | 3.24932050 |
| 85 | quinone biosynthetic process (GO:1901663) | 3.24932050 |
| 86 | regulation of striated muscle contraction (GO:0006942) | 3.24885919 |
| 87 | negative regulation of norepinephrine secretion (GO:0010700) | 3.24117474 |
| 88 | cell communication involved in cardiac conduction (GO:0086065) | 3.23068631 |
| 89 | oxaloacetate metabolic process (GO:0006107) | 3.22674469 |
| 90 | definitive hemopoiesis (GO:0060216) | 3.22357951 |
| 91 | response to inactivity (GO:0014854) | 3.22037005 |
| 92 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.22013633 |
| 93 | erythrocyte maturation (GO:0043249) | 3.21727492 |
| 94 | positive regulation of granulocyte differentiation (GO:0030854) | 3.20220645 |
| 95 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.18086274 |
| 96 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.18086274 |
| 97 | actomyosin structure organization (GO:0031032) | 3.17668319 |
| 98 | regulation of membrane repolarization (GO:0060306) | 3.17661994 |
| 99 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.16104790 |
| 100 | platelet formation (GO:0030220) | 3.15987926 |
| 101 | cardiac muscle cell development (GO:0055013) | 3.15088235 |
| 102 | tetrapyrrole metabolic process (GO:0033013) | 3.14296852 |
| 103 | regulation of necroptotic process (GO:0060544) | 3.13614318 |
| 104 | erythrocyte development (GO:0048821) | 3.11300576 |
| 105 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.10887353 |
| 106 | skeletal muscle fiber development (GO:0048741) | 3.07185521 |
| 107 | tricarboxylic acid metabolic process (GO:0072350) | 3.05529958 |
| 108 | megakaryocyte development (GO:0035855) | 3.04342494 |
| 109 | response to muscle activity (GO:0014850) | 3.02007731 |
| 110 | muscle system process (GO:0003012) | 3.01826503 |
| 111 | adrenergic receptor signaling pathway (GO:0071875) | 3.01239169 |
| 112 | relaxation of cardiac muscle (GO:0055119) | 3.00597257 |
| 113 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.00515175 |
| 114 | regulation of platelet activation (GO:0010543) | 3.00367359 |
| 115 | melanin metabolic process (GO:0006582) | 2.99871934 |
| 116 | COPI coating of Golgi vesicle (GO:0048205) | 2.97682019 |
| 117 | Golgi transport vesicle coating (GO:0048200) | 2.97682019 |
| 118 | muscle tissue morphogenesis (GO:0060415) | 2.93000674 |
| 119 | purine nucleotide salvage (GO:0032261) | 2.91899194 |
| 120 | granulocyte differentiation (GO:0030851) | 2.91890413 |
| 121 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.91256403 |
| 122 | glycogen catabolic process (GO:0005980) | 2.91105617 |
| 123 | cytidine deamination (GO:0009972) | 2.90094661 |
| 124 | cytidine metabolic process (GO:0046087) | 2.90094661 |
| 125 | cytidine catabolic process (GO:0006216) | 2.90094661 |
| 126 | heart trabecula formation (GO:0060347) | 2.89777402 |
| 127 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.88291384 |
| 128 | myotube cell development (GO:0014904) | 2.86545325 |
| 129 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.84580038 |
| 130 | cardiac cell development (GO:0055006) | 2.83105333 |
| 131 | regulation of erythrocyte differentiation (GO:0045646) | 2.82180851 |
| 132 | regulation of sulfur metabolic process (GO:0042762) | 2.80816704 |
| 133 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.80208904 |
| 134 | ubiquinone metabolic process (GO:0006743) | 2.80145393 |
| 135 | cardiac muscle hypertrophy (GO:0003300) | 2.80122197 |
| 136 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.79210741 |
| 137 | neuronal action potential propagation (GO:0019227) | 2.79076205 |
| 138 | glucan catabolic process (GO:0009251) | 2.78893305 |
| 139 | inner mitochondrial membrane organization (GO:0007007) | 2.78825943 |
| 140 | striated muscle atrophy (GO:0014891) | 2.76444839 |
| 141 | glycogen biosynthetic process (GO:0005978) | 2.75640411 |
| 142 | glucan biosynthetic process (GO:0009250) | 2.75640411 |
| 143 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.74769440 |
| 144 | response to thyroid hormone (GO:0097066) | 2.74335004 |
| 145 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.72176634 |
| 146 | positive regulation of myotube differentiation (GO:0010831) | 2.72154384 |
| 147 | negative regulation of muscle contraction (GO:0045932) | 2.71708233 |
| 148 | negative regulation of necrotic cell death (GO:0060547) | 2.71273024 |
| 149 | cellular polysaccharide catabolic process (GO:0044247) | 2.71175586 |
| 150 | regulation of receptor recycling (GO:0001919) | 2.68705623 |
| 151 | cellular response to epinephrine stimulus (GO:0071872) | 2.68310478 |
| 152 | striated muscle hypertrophy (GO:0014897) | 2.65934606 |
| 153 | negative regulation of protein localization to cell surface (GO:2000009) | 2.62380651 |
| 154 | striated muscle adaptation (GO:0014888) | 2.62338162 |
| 155 | cellular response to dexamethasone stimulus (GO:0071549) | 2.59356764 |
| 156 | negative regulation of focal adhesion assembly (GO:0051895) | 2.57895092 |
| 157 | negative regulation of cell junction assembly (GO:1901889) | 2.57895092 |
| 158 | negative regulation of adherens junction organization (GO:1903392) | 2.57895092 |
| 159 | response to methylmercury (GO:0051597) | 2.57275737 |
| 160 | thrombin receptor signaling pathway (GO:0070493) | 2.54388695 |
| 161 | pigment biosynthetic process (GO:0046148) | 2.53628618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 6.78307310 |
| 2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.34461229 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.84666511 |
| 4 | * GATA1_19941826_ChIP-Seq_K562_Human | 3.54005277 |
| 5 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 3.12813167 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.06808190 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.96363568 |
| 8 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.86555838 |
| 9 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.85793037 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.84105911 |
| 11 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.68218620 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.47844110 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.32751859 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.29917679 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29689217 |
| 16 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22925370 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.16322383 |
| 18 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.12658700 |
| 19 | NCOR1_26117541_ChIP-Seq_K562_Human | 2.10084345 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07615620 |
| 21 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.07459460 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95962201 |
| 23 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.94505443 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.86106951 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85380517 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83071095 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82303178 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.78746174 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77941383 |
| 30 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.77870865 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.77390428 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77222959 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75180537 |
| 34 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.73358654 |
| 35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.72458637 |
| 36 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.72278380 |
| 37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.72025706 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68745703 |
| 39 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.68475862 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64422358 |
| 41 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.62164028 |
| 42 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.61669572 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60389345 |
| 44 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.59886395 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59070089 |
| 46 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.57470414 |
| 47 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.57470414 |
| 48 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.54029442 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53875380 |
| 50 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.52317587 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.50083067 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48606189 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.48160982 |
| 54 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.48146410 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47236629 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46581477 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.46308434 |
| 58 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.44479547 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42794731 |
| 60 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.41708081 |
| 61 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.40913458 |
| 62 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.37208442 |
| 63 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36973014 |
| 64 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35742631 |
| 65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.34721678 |
| 66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34143240 |
| 67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33172561 |
| 68 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32988983 |
| 69 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31573902 |
| 70 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.31096751 |
| 71 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.30956189 |
| 72 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.30124532 |
| 73 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29292321 |
| 74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28729173 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27058669 |
| 76 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23974415 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23619590 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23311242 |
| 79 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22152138 |
| 80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21943469 |
| 81 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.21822603 |
| 82 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21224408 |
| 83 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.18761027 |
| 84 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18009813 |
| 85 | MYB_26560356_Chip-Seq_TH2_Human | 1.17896772 |
| 86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15938270 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15893891 |
| 88 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15338645 |
| 89 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15078835 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.14678346 |
| 91 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13511862 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13388525 |
| 93 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.11993393 |
| 94 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10972446 |
| 95 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.10844694 |
| 96 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.10443934 |
| 97 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.10321494 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10223600 |
| 99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09951416 |
| 100 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09671402 |
| 101 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09647350 |
| 102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09255648 |
| 103 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07304158 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06296234 |
| 105 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.05162851 |
| 106 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.05012880 |
| 107 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.04682187 |
| 108 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03688177 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03644982 |
| 110 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.03620803 |
| 111 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03617599 |
| 112 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02303964 |
| 113 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.01519909 |
| 114 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01432351 |
| 115 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01419055 |
| 116 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01042673 |
| 117 | * P68_20966046_ChIP-Seq_HELA_Human | 1.00850442 |
| 118 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.99568034 |
| 119 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99037767 |
| 120 | MYB_26560356_Chip-Seq_TH1_Human | 0.98332064 |
| 121 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98304957 |
| 122 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.98292178 |
| 123 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97841238 |
| 124 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.97563355 |
| 125 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.97350043 |
| 126 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.96318994 |
| 127 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95676648 |
| 128 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.95546955 |
| 129 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95439896 |
| 130 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.94899792 |
| 131 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94386243 |
| 132 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94316875 |
| 133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93894576 |
| 134 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93794558 |
| 135 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.93734282 |
| 136 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92975544 |
| 137 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92387291 |
| 138 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91985441 |
| 139 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.90962699 |
| 140 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89897818 |
| 141 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89329716 |
| 142 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.89148566 |
| 143 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89062275 |
| 144 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.88434272 |
| 145 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87739127 |
| 146 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87269334 |
| 147 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.87179184 |
| 148 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.86722873 |
| 149 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.86712906 |
| 150 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.85211613 |
| 151 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84565174 |
| 152 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82682007 |
| 153 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81358242 |
| 154 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.80290489 |
| 155 | ATF3_27146783_Chip-Seq_COLON_Human | 0.80246508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.69423968 |
| 2 | MP0004147_increased_porphyrin_level | 4.59713664 |
| 3 | MP0003646_muscle_fatigue | 4.23261756 |
| 4 | MP0000749_muscle_degeneration | 4.04613190 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 3.84513228 |
| 6 | MP0005451_abnormal_body_composition | 3.72626590 |
| 7 | MP0000751_myopathy | 3.65733722 |
| 8 | MP0004084_abnormal_cardiac_muscle | 3.64705105 |
| 9 | MP0004036_abnormal_muscle_relaxation | 3.49510152 |
| 10 | MP0005464_abnormal_platelet_physiology | 3.41711892 |
| 11 | MP0004215_abnormal_myocardial_fiber | 3.39493703 |
| 12 | MP0004145_abnormal_muscle_electrophysio | 3.07771923 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.98571818 |
| 14 | MP0005171_absent_coat_pigmentation | 2.95601216 |
| 15 | MP0005330_cardiomyopathy | 2.65967157 |
| 16 | MP0006036_abnormal_mitochondrial_physio | 2.65414108 |
| 17 | MP0004043_abnormal_pH_regulation | 2.42371447 |
| 18 | MP0005620_abnormal_muscle_contractility | 2.40705182 |
| 19 | MP0002972_abnormal_cardiac_muscle | 2.31654533 |
| 20 | MP0008775_abnormal_heart_ventricle | 2.22094538 |
| 21 | MP0002106_abnormal_muscle_physiology | 2.11950874 |
| 22 | MP0002332_abnormal_exercise_endurance | 2.09338631 |
| 23 | MP0004087_abnormal_muscle_fiber | 2.09278255 |
| 24 | MP0000747_muscle_weakness | 2.09077729 |
| 25 | MP0003303_peritoneal_inflammation | 2.06040298 |
| 26 | MP0004859_abnormal_synaptic_plasticity | 2.04145340 |
| 27 | MP0001545_abnormal_hematopoietic_system | 1.98374436 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.98374436 |
| 29 | MP0004484_altered_response_of | 1.97509308 |
| 30 | MP0002269_muscular_atrophy | 1.96706882 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.94080730 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.93734836 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.91637143 |
| 34 | MP0008260_abnormal_autophagy | 1.87879370 |
| 35 | MP0004510_myositis | 1.87525037 |
| 36 | MP0000759_abnormal_skeletal_muscle | 1.84286364 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.81936355 |
| 38 | MP0004130_abnormal_muscle_cell | 1.80326891 |
| 39 | MP0004085_abnormal_heartbeat | 1.76793548 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.68014668 |
| 41 | MP0005369_muscle_phenotype | 1.66821904 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.62463847 |
| 43 | MP0003221_abnormal_cardiomyocyte_apopto | 1.59274964 |
| 44 | MP0001544_abnormal_cardiovascular_syste | 1.57012077 |
| 45 | MP0005385_cardiovascular_system_phenoty | 1.57012077 |
| 46 | MP0003724_increased_susceptibility_to | 1.54429028 |
| 47 | MP0008004_abnormal_stomach_pH | 1.45685400 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.45579297 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.41815550 |
| 50 | MP0002132_abnormal_respiratory_system | 1.39645839 |
| 51 | MP0004270_analgesia | 1.37287160 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.35947853 |
| 53 | MP0010630_abnormal_cardiac_muscle | 1.35781186 |
| 54 | MP0006138_congestive_heart_failure | 1.33192868 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.32935257 |
| 56 | MP0004233_abnormal_muscle_weight | 1.32293037 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.30893867 |
| 58 | MP0004381_abnormal_hair_follicle | 1.28583924 |
| 59 | MP0000343_altered_response_to | 1.28397557 |
| 60 | MP0003122_maternal_imprinting | 1.26731221 |
| 61 | MP0005535_abnormal_body_temperature | 1.26439262 |
| 62 | MP0003283_abnormal_digestive_organ | 1.22265198 |
| 63 | MP0005310_abnormal_salivary_gland | 1.21970223 |
| 64 | MP0003136_yellow_coat_color | 1.17022403 |
| 65 | MP0002693_abnormal_pancreas_physiology | 1.14493258 |
| 66 | MP0003880_abnormal_central_pattern | 1.13159071 |
| 67 | MP0003635_abnormal_synaptic_transmissio | 1.12872654 |
| 68 | MP0002735_abnormal_chemical_nociception | 1.12274108 |
| 69 | MP0009278_abnormal_bone_marrow | 1.11676554 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 1.10747179 |
| 71 | MP0006035_abnormal_mitochondrial_morpho | 1.10739210 |
| 72 | MP0000230_abnormal_systemic_arterial | 1.08850981 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 1.08336854 |
| 74 | MP0005083_abnormal_biliary_tract | 1.06295359 |
| 75 | MP0002095_abnormal_skin_pigmentation | 1.06055263 |
| 76 | MP0003436_decreased_susceptibility_to | 1.03180258 |
| 77 | MP0002736_abnormal_nociception_after | 1.03167372 |
| 78 | MP0002234_abnormal_pharynx_morphology | 1.02695741 |
| 79 | MP0002822_catalepsy | 1.02300140 |
| 80 | MP0001765_abnormal_ion_homeostasis | 1.01452058 |
| 81 | MP0001529_abnormal_vocalization | 1.01038632 |
| 82 | MP0003879_abnormal_hair_cell | 0.99366401 |
| 83 | MP0009745_abnormal_behavioral_response | 0.99063583 |
| 84 | MP0001968_abnormal_touch/_nociception | 0.97640684 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.96971633 |
| 86 | MP0000003_abnormal_adipose_tissue | 0.96738683 |
| 87 | MP0002734_abnormal_mechanical_nocicepti | 0.94994401 |
| 88 | MP0010386_abnormal_urinary_bladder | 0.94419415 |
| 89 | MP0002419_abnormal_innate_immunity | 0.92981912 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.92621156 |
| 91 | MP0005266_abnormal_metabolism | 0.91981667 |
| 92 | MP0002398_abnormal_bone_marrow | 0.91748680 |
| 93 | MP0003828_pulmonary_edema | 0.90879412 |
| 94 | MP0003191_abnormal_cellular_cholesterol | 0.90373972 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.90154569 |
| 96 | MP0005025_abnormal_response_to | 0.89918670 |
| 97 | MP0003186_abnormal_redox_activity | 0.89828073 |
| 98 | MP0005408_hypopigmentation | 0.89019854 |
| 99 | MP0001835_abnormal_antigen_presentation | 0.88343002 |
| 100 | MP0009840_abnormal_foam_cell | 0.85103339 |
| 101 | MP0006276_abnormal_autonomic_nervous | 0.83783619 |
| 102 | MP0002272_abnormal_nervous_system | 0.83357901 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.82909607 |
| 104 | MP0002971_abnormal_brown_adipose | 0.81744325 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 0.81216530 |
| 106 | MP0002064_seizures | 0.79175481 |
| 107 | MP0008569_lethality_at_weaning | 0.78990793 |
| 108 | MP0002733_abnormal_thermal_nociception | 0.78837438 |
| 109 | MP0002063_abnormal_learning/memory/cond | 0.78727752 |
| 110 | MP0000689_abnormal_spleen_morphology | 0.78637487 |
| 111 | MP0001661_extended_life_span | 0.77817638 |
| 112 | MP0001440_abnormal_grooming_behavior | 0.77512747 |
| 113 | MP0001970_abnormal_pain_threshold | 0.77281571 |
| 114 | MP0000266_abnormal_heart_morphology | 0.76842243 |
| 115 | MP0005670_abnormal_white_adipose | 0.76623160 |
| 116 | MP0000371_diluted_coat_color | 0.75810624 |
| 117 | MP0003045_fibrosis | 0.75660882 |
| 118 | MP0005386_behavior/neurological_phenoty | 0.75323005 |
| 119 | MP0004924_abnormal_behavior | 0.75323005 |
| 120 | MP0002148_abnormal_hypersensitivity_rea | 0.74376710 |
| 121 | MP0005165_increased_susceptibility_to | 0.73842010 |
| 122 | MP0002067_abnormal_sensory_capabilities | 0.73742686 |
| 123 | MP0002722_abnormal_immune_system | 0.73243397 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.72978419 |
| 125 | MP0001944_abnormal_pancreas_morphology | 0.72724843 |
| 126 | MP0009785_altered_susceptibility_to | 0.72586123 |
| 127 | MP0005000_abnormal_immune_tolerance | 0.72203952 |
| 128 | MP0000685_abnormal_immune_system | 0.72185542 |
| 129 | MP0002127_abnormal_cardiovascular_syste | 0.71880116 |
| 130 | MP0003195_calcinosis | 0.71575015 |
| 131 | MP0005646_abnormal_pituitary_gland | 0.69343505 |
| 132 | MP0008872_abnormal_physiological_respon | 0.68456959 |
| 133 | MP0000678_abnormal_parathyroid_gland | 0.67617970 |
| 134 | MP0005375_adipose_tissue_phenotype | 0.66866266 |
| 135 | MP0009764_decreased_sensitivity_to | 0.66810014 |
| 136 | MP0002429_abnormal_blood_cell | 0.65963240 |
| 137 | MP0000733_abnormal_muscle_development | 0.65908229 |
| 138 | MP0009333_abnormal_splenocyte_physiolog | 0.65328384 |
| 139 | MP0002420_abnormal_adaptive_immunity | 0.65191075 |
| 140 | MP0003300_gastrointestinal_ulcer | 0.64268026 |
| 141 | MP0001790_abnormal_immune_system | 0.63858866 |
| 142 | MP0005387_immune_system_phenotype | 0.63858866 |
| 143 | MP0001819_abnormal_immune_cell | 0.63630295 |
| 144 | MP0009643_abnormal_urine_homeostasis | 0.63621602 |
| 145 | MP0001905_abnormal_dopamine_level | 0.62982986 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.61630365 |
| 147 | MP0002572_abnormal_emotion/affect_behav | 0.61323835 |
| 148 | MP0008995_early_reproductive_senescence | 0.59524263 |
| 149 | MP0002723_abnormal_immune_serum | 0.59114982 |
| 150 | MP0003953_abnormal_hormone_level | 0.58488268 |
| 151 | MP0009763_increased_sensitivity_to | 0.58085757 |
| 152 | MP0009046_muscle_twitch | 0.57279259 |
| 153 | MP0004811_abnormal_neuron_physiology | 0.56635118 |
| 154 | MP0005595_abnormal_vascular_smooth | 0.54181273 |
| 155 | MP0005379_endocrine/exocrine_gland_phen | 0.53700846 |
| 156 | MP0005452_abnormal_adipose_tissue | 0.51321438 |
| 157 | MP0010368_abnormal_lymphatic_system | 0.49661393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.84359051 |
| 2 | Myoglobinuria (HP:0002913) | 5.00957688 |
| 3 | Sudden death (HP:0001699) | 4.90378253 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 4.86641700 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.81544293 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 4.77097867 |
| 7 | Prolonged bleeding time (HP:0003010) | 4.72568854 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.58335120 |
| 9 | Poikilocytosis (HP:0004447) | 4.28305706 |
| 10 | Hypochromic microcytic anemia (HP:0004840) | 3.99043414 |
| 11 | Reticulocytosis (HP:0001923) | 3.90151803 |
| 12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.86980163 |
| 13 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.80731741 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.77638185 |
| 15 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.69113137 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 3.56852340 |
| 17 | Atrial fibrillation (HP:0005110) | 3.41882850 |
| 18 | Hepatic necrosis (HP:0002605) | 3.40032158 |
| 19 | Distal lower limb muscle weakness (HP:0009053) | 3.39119722 |
| 20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.36923911 |
| 21 | Subaortic stenosis (HP:0001682) | 3.36923911 |
| 22 | Palpitations (HP:0001962) | 3.34522314 |
| 23 | Cholelithiasis (HP:0001081) | 3.34149454 |
| 24 | Ventricular tachycardia (HP:0004756) | 3.32432995 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.24526278 |
| 26 | Neck muscle weakness (HP:0000467) | 3.22013974 |
| 27 | Primary atrial arrhythmia (HP:0001692) | 3.19912255 |
| 28 | Acute encephalopathy (HP:0006846) | 3.19376682 |
| 29 | Purpura (HP:0000979) | 3.16941489 |
| 30 | Mitochondrial inheritance (HP:0001427) | 3.16292788 |
| 31 | Bundle branch block (HP:0011710) | 3.15513415 |
| 32 | Rhabdomyolysis (HP:0003201) | 3.13851326 |
| 33 | Supraventricular tachycardia (HP:0004755) | 3.13737862 |
| 34 | Muscle fiber splitting (HP:0003555) | 3.13412379 |
| 35 | Round ear (HP:0100830) | 3.11603975 |
| 36 | Diaphragmatic weakness (HP:0009113) | 3.11445230 |
| 37 | EMG: myopathic abnormalities (HP:0003458) | 3.10990539 |
| 38 | Abnormal gallbladder morphology (HP:0012437) | 3.10602927 |
| 39 | Hepatocellular necrosis (HP:0001404) | 3.07955062 |
| 40 | Ragged-red muscle fibers (HP:0003200) | 3.07405844 |
| 41 | Supraventricular arrhythmia (HP:0005115) | 3.05847216 |
| 42 | Abnormal platelet volume (HP:0011876) | 3.04723329 |
| 43 | Ulnar deviation of the wrist (HP:0003049) | 3.02838684 |
| 44 | Increased mean platelet volume (HP:0011877) | 3.02703016 |
| 45 | Myotonia (HP:0002486) | 3.00527881 |
| 46 | Progressive macrocephaly (HP:0004481) | 2.99877994 |
| 47 | Epistaxis (HP:0000421) | 2.97555325 |
| 48 | Acanthocytosis (HP:0001927) | 2.95951440 |
| 49 | Pheochromocytoma (HP:0002666) | 2.95141695 |
| 50 | Microcytic anemia (HP:0001935) | 2.93996855 |
| 51 | Menorrhagia (HP:0000132) | 2.91699778 |
| 52 | Prolonged QT interval (HP:0001657) | 2.91429210 |
| 53 | Progressive muscle weakness (HP:0003323) | 2.90298042 |
| 54 | Areflexia of lower limbs (HP:0002522) | 2.89501731 |
| 55 | Ketoacidosis (HP:0001993) | 2.89217593 |
| 56 | Lipoatrophy (HP:0100578) | 2.84055780 |
| 57 | Increased CSF lactate (HP:0002490) | 2.79953390 |
| 58 | Syncope (HP:0001279) | 2.78321916 |
| 59 | Hypoglycemic coma (HP:0001325) | 2.75219176 |
| 60 | Neuroendocrine neoplasm (HP:0100634) | 2.74630167 |
| 61 | Dilated cardiomyopathy (HP:0001644) | 2.74601091 |
| 62 | Paralysis (HP:0003470) | 2.72017475 |
| 63 | EMG: neuropathic changes (HP:0003445) | 2.65140907 |
| 64 | Generalized aminoaciduria (HP:0002909) | 2.61163250 |
| 65 | Muscle fiber inclusion bodies (HP:0100299) | 2.60171769 |
| 66 | Frequent falls (HP:0002359) | 2.57579285 |
| 67 | Hyporeflexia of lower limbs (HP:0002600) | 2.57080391 |
| 68 | Exercise intolerance (HP:0003546) | 2.52492367 |
| 69 | Heart block (HP:0012722) | 2.51772127 |
| 70 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.51750589 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.50267582 |
| 72 | Polycythemia (HP:0001901) | 2.49435791 |
| 73 | Lactic acidosis (HP:0003128) | 2.46336756 |
| 74 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.46039464 |
| 75 | Abnormal atrioventricular conduction (HP:0005150) | 2.43730848 |
| 76 | Increased intramyocellular lipid droplets (HP:0012240) | 2.42394240 |
| 77 | Abnormal EKG (HP:0003115) | 2.42309055 |
| 78 | Muscle stiffness (HP:0003552) | 2.41383671 |
| 79 | Abnormal hemoglobin (HP:0011902) | 2.41337455 |
| 80 | Atrioventricular block (HP:0001678) | 2.40595781 |
| 81 | Hyperbilirubinemia (HP:0002904) | 2.35637391 |
| 82 | Left ventricular hypertrophy (HP:0001712) | 2.34786135 |
| 83 | Ventricular arrhythmia (HP:0004308) | 2.34465183 |
| 84 | Gingival bleeding (HP:0000225) | 2.33880984 |
| 85 | Hypochromic anemia (HP:0001931) | 2.32746098 |
| 86 | Testicular atrophy (HP:0000029) | 2.30749954 |
| 87 | Bulbar palsy (HP:0001283) | 2.30408966 |
| 88 | Decreased circulating renin level (HP:0003351) | 2.29736949 |
| 89 | Ventricular fibrillation (HP:0001663) | 2.29433603 |
| 90 | Distal lower limb amyotrophy (HP:0008944) | 2.28655566 |
| 91 | Impaired platelet aggregation (HP:0003540) | 2.28362553 |
| 92 | Abnormal platelet function (HP:0011869) | 2.28362553 |
| 93 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.26137578 |
| 94 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.26137578 |
| 95 | Calcaneovalgus deformity (HP:0001848) | 2.25870969 |
| 96 | Visual hallucinations (HP:0002367) | 2.21965431 |
| 97 | Anxiety (HP:0000739) | 2.19456261 |
| 98 | Type 1 muscle fiber predominance (HP:0003803) | 2.18357216 |
| 99 | Large for gestational age (HP:0001520) | 2.17920791 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 2.16908685 |
| 101 | Malignant hyperthermia (HP:0002047) | 2.16582128 |
| 102 | Generalized muscle weakness (HP:0003324) | 2.15619470 |
| 103 | Spontaneous hematomas (HP:0007420) | 2.11153790 |
| 104 | Difficulty running (HP:0009046) | 2.10924631 |
| 105 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.10619980 |
| 106 | Respiratory failure (HP:0002878) | 2.08991327 |
| 107 | Difficulty climbing stairs (HP:0003551) | 2.08596639 |
| 108 | Cholecystitis (HP:0001082) | 2.07809935 |
| 109 | Abnormal gallbladder physiology (HP:0012438) | 2.07809935 |
| 110 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.06094927 |
| 111 | Abnormality of alanine metabolism (HP:0010916) | 2.06094927 |
| 112 | Hyperalaninemia (HP:0003348) | 2.06094927 |
| 113 | Weak cry (HP:0001612) | 2.05675400 |
| 114 | Nemaline bodies (HP:0003798) | 2.05256233 |
| 115 | Cerebral edema (HP:0002181) | 2.04772574 |
| 116 | Poor eye contact (HP:0000817) | 2.03043288 |
| 117 | Absent phalangeal crease (HP:0006109) | 2.02205550 |
| 118 | Increased serum ferritin (HP:0003281) | 2.02087934 |
| 119 | Rimmed vacuoles (HP:0003805) | 2.01820011 |
| 120 | Febrile seizures (HP:0002373) | 2.01128330 |
| 121 | Abnormality of reticulocytes (HP:0004312) | 2.00910792 |
| 122 | Increased connective tissue (HP:0009025) | 2.00291699 |
| 123 | Gout (HP:0001997) | 1.99821993 |
| 124 | Petechiae (HP:0000967) | 1.98694941 |
| 125 | Late onset (HP:0003584) | 1.96934203 |
| 126 | Tinnitus (HP:0000360) | 1.96073012 |
| 127 | Hyperthyroidism (HP:0000836) | 1.95681976 |
| 128 | Albinism (HP:0001022) | 1.95646349 |
| 129 | Hyperkalemia (HP:0002153) | 1.95502192 |
| 130 | Scapular winging (HP:0003691) | 1.94775801 |
| 131 | Deformed tarsal bones (HP:0008119) | 1.92212962 |
| 132 | Abnormality of the gallbladder (HP:0005264) | 1.92210887 |
| 133 | Generalized tonic-clonic seizures (HP:0002069) | 1.91294569 |
| 134 | Distal arthrogryposis (HP:0005684) | 1.91093203 |
| 135 | Abnormality of the foot musculature (HP:0001436) | 1.90860666 |
| 136 | Abnormal pupillary function (HP:0007686) | 1.90483133 |
| 137 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89974431 |
| 138 | Myopathic facies (HP:0002058) | 1.89905265 |
| 139 | Foot dorsiflexor weakness (HP:0009027) | 1.89528665 |
| 140 | Slender build (HP:0001533) | 1.89457848 |
| 141 | Ileus (HP:0002595) | 1.87368097 |
| 142 | Toxemia of pregnancy (HP:0100603) | 1.84109307 |
| 143 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82033475 |
| 144 | Hypertensive crisis (HP:0100735) | 1.81495800 |
| 145 | Fatigue (HP:0012378) | 1.79940116 |
| 146 | Stomatitis (HP:0010280) | 1.79373553 |
| 147 | Ocular albinism (HP:0001107) | 1.74522727 |
| 148 | Gowers sign (HP:0003391) | 1.72828694 |
| 149 | Nausea (HP:0002018) | 1.71603131 |
| 150 | Spinal rigidity (HP:0003306) | 1.70326321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.11237050 |
| 2 | TTN | 2.94312225 |
| 3 | MYLK | 2.84967156 |
| 4 | EIF2AK1 | 2.80759196 |
| 5 | PHKG2 | 2.71542796 |
| 6 | PHKG1 | 2.71542796 |
| 7 | MUSK | 2.69087908 |
| 8 | NEK1 | 2.47786122 |
| 9 | TAOK2 | 2.44342632 |
| 10 | NME1 | 2.41638677 |
| 11 | WNK4 | 2.38008706 |
| 12 | MAP3K12 | 2.23768604 |
| 13 | PDK4 | 2.19580942 |
| 14 | PDK3 | 2.19580942 |
| 15 | BCKDK | 2.15521060 |
| 16 | PINK1 | 2.00195150 |
| 17 | TRIB3 | 1.98278453 |
| 18 | NTRK3 | 1.96108498 |
| 19 | BMX | 1.92883105 |
| 20 | INSRR | 1.91415265 |
| 21 | PRKD3 | 1.83373241 |
| 22 | LMTK2 | 1.82450051 |
| 23 | PRPF4B | 1.78505891 |
| 24 | STK24 | 1.73215153 |
| 25 | TIE1 | 1.61628339 |
| 26 | PKN2 | 1.60235298 |
| 27 | FLT3 | 1.54404913 |
| 28 | MAPKAPK3 | 1.46613468 |
| 29 | MARK3 | 1.44845603 |
| 30 | GRK6 | 1.42661119 |
| 31 | ZAP70 | 1.38376472 |
| 32 | ARAF | 1.34924820 |
| 33 | GRK5 | 1.33524245 |
| 34 | BRSK1 | 1.33395430 |
| 35 | BLK | 1.32965438 |
| 36 | TRPM7 | 1.30102250 |
| 37 | MAP3K11 | 1.29362163 |
| 38 | CAMKK2 | 1.28791957 |
| 39 | TAOK1 | 1.24596720 |
| 40 | SYK | 1.23567910 |
| 41 | CDC42BPA | 1.23168735 |
| 42 | TNK2 | 1.21688355 |
| 43 | GRK7 | 1.16713256 |
| 44 | PDK2 | 1.14167736 |
| 45 | DMPK | 1.12129113 |
| 46 | MAP3K4 | 1.12068828 |
| 47 | TEC | 1.10912520 |
| 48 | MAP3K1 | 1.07349485 |
| 49 | BTK | 1.07268933 |
| 50 | BRAF | 1.05018352 |
| 51 | PASK | 1.02129174 |
| 52 | TBK1 | 1.02089724 |
| 53 | MAP2K3 | 1.00994416 |
| 54 | KDR | 1.00853460 |
| 55 | RPS6KA2 | 0.99762602 |
| 56 | MAP2K7 | 0.98354301 |
| 57 | TYK2 | 0.93410055 |
| 58 | MAP4K1 | 0.91042936 |
| 59 | PTK2B | 0.89406987 |
| 60 | MAPK15 | 0.89139699 |
| 61 | JAK3 | 0.88879702 |
| 62 | NTRK1 | 0.88559048 |
| 63 | MAP2K4 | 0.88275569 |
| 64 | ERN1 | 0.88212053 |
| 65 | HIPK2 | 0.88080245 |
| 66 | DAPK1 | 0.87637333 |
| 67 | HCK | 0.86889542 |
| 68 | KSR2 | 0.86681161 |
| 69 | UHMK1 | 0.85585496 |
| 70 | MINK1 | 0.85130536 |
| 71 | CLK1 | 0.81369426 |
| 72 | CCNB1 | 0.78415492 |
| 73 | WNK3 | 0.75961481 |
| 74 | SGK2 | 0.74931646 |
| 75 | FGR | 0.74779209 |
| 76 | ILK | 0.74228105 |
| 77 | PIM1 | 0.74154643 |
| 78 | FES | 0.72881922 |
| 79 | RAF1 | 0.72129430 |
| 80 | DYRK1B | 0.72020463 |
| 81 | JAK2 | 0.71988882 |
| 82 | RIPK4 | 0.71984740 |
| 83 | MAPK12 | 0.69984942 |
| 84 | RPS6KC1 | 0.69883258 |
| 85 | RPS6KL1 | 0.69883258 |
| 86 | CSK | 0.68561154 |
| 87 | PIK3CA | 0.68271356 |
| 88 | STK16 | 0.67338323 |
| 89 | SGK3 | 0.66226470 |
| 90 | PRKAA1 | 0.66095014 |
| 91 | MATK | 0.65671411 |
| 92 | MAP3K7 | 0.65669083 |
| 93 | DAPK3 | 0.64988670 |
| 94 | ZAK | 0.63656453 |
| 95 | CDK5 | 0.62651316 |
| 96 | MAP2K1 | 0.62490734 |
| 97 | MAP3K2 | 0.61425490 |
| 98 | ROCK1 | 0.61321861 |
| 99 | PRKAA2 | 0.60702742 |
| 100 | IKBKE | 0.60469752 |
| 101 | IRAK4 | 0.59282745 |
| 102 | CAMK2D | 0.58574875 |
| 103 | MAP3K6 | 0.57848539 |
| 104 | EPHB1 | 0.57742489 |
| 105 | RPS6KA6 | 0.57570269 |
| 106 | CAMK2A | 0.57259625 |
| 107 | BRSK2 | 0.57236241 |
| 108 | IKBKB | 0.56850756 |
| 109 | EPHA4 | 0.56366512 |
| 110 | MAP2K6 | 0.56338320 |
| 111 | PRKD2 | 0.55911704 |
| 112 | PDPK1 | 0.55413270 |
| 113 | ICK | 0.55384514 |
| 114 | PRKCH | 0.54777818 |
| 115 | MAPK11 | 0.54355855 |
| 116 | NEK9 | 0.54163524 |
| 117 | DAPK2 | 0.53852463 |
| 118 | IRAK3 | 0.52747423 |
| 119 | SGK494 | 0.52623337 |
| 120 | SGK223 | 0.52623337 |
| 121 | CDK19 | 0.51461003 |
| 122 | PRKACA | 0.50985339 |
| 123 | CAMKK1 | 0.50779689 |
| 124 | PRKACG | 0.49693610 |
| 125 | MARK2 | 0.49522786 |
| 126 | MAP3K13 | 0.49360772 |
| 127 | MAP3K5 | 0.49243510 |
| 128 | MAPKAPK5 | 0.49175036 |
| 129 | PAK3 | 0.48887583 |
| 130 | AKT2 | 0.48697416 |
| 131 | LYN | 0.47813731 |
| 132 | CAMK1 | 0.45599793 |
| 133 | MAP3K3 | 0.45377944 |
| 134 | MAPK4 | 0.45182139 |
| 135 | CDK8 | 0.45154057 |
| 136 | TAOK3 | 0.44513422 |
| 137 | STK4 | 0.43753629 |
| 138 | SGK1 | 0.43327521 |
| 139 | PDK1 | 0.43028028 |
| 140 | PIK3CG | 0.41951118 |
| 141 | PRKD1 | 0.40505400 |
| 142 | SCYL2 | 0.39260206 |
| 143 | MAPK7 | 0.35949287 |
| 144 | PAK1 | 0.34670246 |
| 145 | BMPR2 | 0.34486548 |
| 146 | MOS | 0.33670085 |
| 147 | PKN1 | 0.31488550 |
| 148 | ITK | 0.31100687 |
| 149 | CAMK4 | 0.29933479 |
| 150 | DYRK3 | 0.29223874 |
| 151 | KSR1 | 0.27579682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.19240174 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.84848911 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.79302395 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.52476611 |
| 5 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.93217474 |
| 6 | Platelet activation_Homo sapiens_hsa04611 | 2.82385790 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.74105187 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.44254464 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.39379330 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.38193782 |
| 11 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.34884407 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.23769864 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.22738635 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.09615595 |
| 15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.09526813 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.08353036 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.95808547 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.87905225 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.80480246 |
| 20 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.74948506 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69946792 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68389400 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61270101 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.53168405 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.50436176 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.45535282 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43450011 |
| 28 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.42611092 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41637661 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38756144 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.34377792 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29951412 |
| 33 | Long-term potentiation_Homo sapiens_hsa04720 | 1.27348331 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.26239461 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.26149431 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25050988 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24031027 |
| 38 | Protein export_Homo sapiens_hsa03060 | 1.23551064 |
| 39 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.21668568 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20592870 |
| 41 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.17540204 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.16042324 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15969119 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14750644 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13384996 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12587936 |
| 47 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.11665277 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10319454 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09925286 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08601179 |
| 51 | Olfactory transduction_Homo sapiens_hsa04740 | 1.08212655 |
| 52 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.07697367 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06104799 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04152488 |
| 55 | Galactose metabolism_Homo sapiens_hsa00052 | 1.04114719 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.01979098 |
| 57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.01151923 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 1.00783315 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 1.00026299 |
| 60 | Taste transduction_Homo sapiens_hsa04742 | 0.99987165 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99697941 |
| 62 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.99572496 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99147604 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96284912 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95139745 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94709474 |
| 67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91383858 |
| 68 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.91146808 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.88358010 |
| 70 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87989960 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87949722 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.87687412 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.87497718 |
| 74 | Renin secretion_Homo sapiens_hsa04924 | 0.87417989 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.86718177 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86389029 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86281169 |
| 78 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85635155 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82207016 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78790023 |
| 81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77278159 |
| 82 | Cocaine addiction_Homo sapiens_hsa05030 | 0.77021228 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76185402 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74665110 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74484339 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73058251 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71933247 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71745602 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.71665172 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71519364 |
| 91 | Gap junction_Homo sapiens_hsa04540 | 0.70087457 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69897726 |
| 93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67161911 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67128265 |
| 95 | Influenza A_Homo sapiens_hsa05164 | 0.66609125 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65578931 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65174066 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64612815 |
| 99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64242767 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64048228 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63552228 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.62676597 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61335456 |
| 104 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60707598 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60568509 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59181247 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58987362 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58573736 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58383877 |
| 110 | Nicotine addiction_Homo sapiens_hsa05033 | 0.58359861 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58354157 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.56968476 |
| 113 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56543352 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.55043219 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53850530 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53825194 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.53606765 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53421922 |
| 119 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53162914 |
| 120 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52956618 |
| 121 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52910011 |
| 122 | Focal adhesion_Homo sapiens_hsa04510 | 0.52176959 |
| 123 | ABC transporters_Homo sapiens_hsa02010 | 0.51372978 |
| 124 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.50840267 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.50542796 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49118468 |
| 127 | Hepatitis B_Homo sapiens_hsa05161 | 0.48850284 |
| 128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47990824 |
| 129 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46537876 |
| 130 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46233028 |
| 131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45974682 |
| 132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45933866 |
| 133 | Legionellosis_Homo sapiens_hsa05134 | 0.45536765 |
| 134 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45178480 |
| 135 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44450554 |
| 136 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44237835 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.43642569 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43384298 |
| 139 | Shigellosis_Homo sapiens_hsa05131 | 0.43339398 |
| 140 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42541961 |
| 141 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42334169 |
| 142 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41450951 |
| 143 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39102808 |
| 144 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35783038 |
| 145 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34735128 |
| 146 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.34408156 |
| 147 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34176933 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33763455 |
| 149 | Alcoholism_Homo sapiens_hsa05034 | 0.31479603 |
| 150 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30945826 |
| 151 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30577938 |
| 152 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29762698 |
| 153 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.29694659 |
| 154 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27580984 |
| 155 | Long-term depression_Homo sapiens_hsa04730 | 0.25933154 |
| 156 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24708744 |
| 157 | Glioma_Homo sapiens_hsa05214 | 0.22103881 |
| 158 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21751230 |
| 159 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.21175075 |
| 160 | Lysosome_Homo sapiens_hsa04142 | 0.20356577 |
| 161 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19948571 |
| 162 | Melanogenesis_Homo sapiens_hsa04916 | 0.18634416 |

